1H-Pyrazolo[4,3-b]pyridine - CAS 272-52-6
Catalog: |
BB019509 |
Product Name: |
1H-Pyrazolo[4,3-b]pyridine |
CAS: |
272-52-6 |
Synonyms: |
1H-pyrazolo[4,3-b]pyridine |
IUPAC Name: | 1H-pyrazolo[4,3-b]pyridine |
Description: | 1H-Pyrazolo[4,3-b]pyridine (CAS# 272-52-6) is a useful research chemical. |
Molecular Weight: | 119.12 |
Molecular Formula: | C6H5N3 |
Canonical SMILES: | C1=CC2=C(C=NN2)N=C1 |
InChI: | InChI=1S/C6H5N3/c1-2-5-6(7-3-1)4-8-9-5/h1-4H,(H,8,9) |
InChI Key: | AMFYRKOUWBAGHV-UHFFFAOYSA-N |
Boiling Point: | 294.466 °C at 760 mmHg |
Purity: | 97.0 % |
Density: | 1.349 g/cm3 |
MDL: | MFCD08234560 |
LogP: | 0.95790 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P322, P330, P332+P313, P337+P313, P362, P363, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113321651-A | Pyrazolopyridine hydroxamic acid compound, and preparation method and application thereof | 20210622 |
CN-112679555-A | Broad-spectrum divalent platinum complex and preparation method and application thereof | 20210114 |
CN-112679494-A | Preparation method of pyrazolo [1,5-a ] pyridine derivative | 20201224 |
CN-112300157-A | Novel pyrazolopyridine compound with anti-tumor activity and preparation method thereof | 20201116 |
CN-112300157-B | Novel pyrazolopyridine compound with anti-tumor activity and preparation method thereof | 20201116 |
PMID | Publication Date | Title | Journal |
24582983 | 20140315 | 4,5-Dihydro-1H-pyrazolo[3,4-d]pyrimidine containing phenothiazines as antitubercular agents | Bioorganic & medicinal chemistry letters |
23089526 | 20121201 | The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of type 2 diabetes mellitus | Bioorganic & medicinal chemistry letters |
22698578 | 20120815 | Antidepressant-like effect of etazolate, a cyclic nucleotide phosphodiesterase 4 inhibitor--an approach using rodent behavioral antidepressant tests battery | European journal of pharmacology |
22412524 | 20120301 | 5,6-Dimethyl-4-(thio-phen-2-yl)-1H-pyrazolo-[3,4-b]pyridin-3-amine | Acta crystallographica. Section E, Structure reports online |
21989734 | 20120201 | Synthesis and antioxidant evaluation of some new pyrazolopyridine derivatives | Archiv der Pharmazie |
Complexity: | 105 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 119.048347172 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 119.048347172 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 41.6 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.6 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Pyridines
Customers Also Viewed
-
[7310-97-6]
2,5-Dimethoxybenzene-1,4-dicarboxaldehyde
-
[138219-98-4]
4,4'-Bis(chloromethyl)-2,2'-bipyridyl
-
[186817-80-1]
2-Ethylhexyl L-lactate
-
[443922-06-3]
4,4',4''-(1,3,5-Triazine-2,4,6-triyl)tris[benzaldehyde]
-
[7194-86-7]
Nonatriacontane
-
[32449-92-6]
D-(+)-Glucurono-3,6-lactone
INDUSTRY LEADERS TRUST OUR PRODUCTS